USPs that matters:

$kyrocking Ca$hcows

AI triggered Signals

ETF InfoDataHub

Visit our new ATH Index-Gate

White Label as a Service

IPO InfoDataHub

Short Selling Radar

2025 Survey * online * | Take part and win

Tipp: Hedge Fund Activity Tracker ("HFAT")

Info-Hub

Newswire
Directors Dealings
DD i/o
Short Selling Radar
HFAT
WWR
FTT
NewAD
Ratings
Vola-Statistics

Tools

Tools/Apps
Lab

Campus

Education
Webinars
Mentoring

Press

FAQ

What's New

Company
- About Us
- Vision/Mission
- IR
- Press
- Career
- Specials
Portfolio
Product
- CFD/FX
- Indices
- Currencies
- Commodities
- Metals
- Stocks & ETFs
- Crypto
- ETP/ETI
- Financial Innovations
Platforms
Institutional/B2B

Home
Terminal
Compugroup Medical SE

Compugroup Medical SE

WHO'M

Digital Profiler. Simply click the AI button

CUSIP

D193ZN100

SEDOL

BK80L42

CIK

N/A

cgm.com

LEI: 529900CUXZGOCJZR7O57

FIGI: BBG000BLD4P0

COP

Compugroup Medical SE

GICS: 35103010 · Sector: - · Sub-Sector: -

PROFILER

BASIC = Free ADVANCED = User Account BUSINESS = Subscription PRIME = Subscription

ENTERPRISE = upon request

PROFILER

BASIC

ADVANCED

BUSINESS

PRIME

AI Insights

CompuGroup Medical

Click to initiate

ENTERPRISE

NAME

Compugroup Medical SE

ISIN

DE000A288904

TICKER

COP

MIC

XETR

REUTERS

COP1n.DE

BLOOMBERG

COP GR

BUILD THEMEFOLIO SHARE IDEAS DISCUSS

LEVERAGE INVEST

Financial Intelligence

360°^iHub Crowd^iFeed ATH Tracker Index Tracker ETF TF Spicy² X-Billboard

X-OVR
FACTSHEET
PEERGROUP
X-News Explorer
L/S SHORT
STUDY
ROOTS
IT’s ME

FOR INVESTORS

FOR TRADERS

Securities Trading Warrants

TradingView ActivTrader MT4 MT5

Directors Dealings

X-Billboard

EQS Newswire

Globe Newswire

PR Newswire

BusinessWire

ACCESSWIRE

ActuNews

Newsfile

EDGAR

EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.

Fri, 03.01.2025

CGM issues joint reasoned statement recommending that shareholders accept CVC's voluntary public takeover offer Offer price of EUR 22.00 per share is considered to be fair and adequate Deutsche Bank and J.P. Morgan have issued fairness opinions confirming the fairness of the offer price from a financial perspective Managing Directors, Adminis...

Research & Analysis

Mon, 09.12.2024

CompuGroup Medical enters into an investment agreement with CVC Capital Partners CVC announces intention to launch a voluntary public tender offer to all free float shareholders CVC to launch voluntary public tender offer for EUR 22.00 per share, subsequent delisting envisaged Significant premium of 51.1% to the 3M VWAP and 33.5% to closing pr...

Research & Analysis

Mon, 09.12.2024

EQS-WpÜG: SCUR-Alpha 269 GmbH (künftig: Caesar BidCo GmbH) / Tender Offer Tender Offer / Target company: CompuGroup Medical SE & Co. KGaA; Bidder: SCUR-Alpha 269 GmbH (in future: Caesar BidCo GmbH) 09.12.2024 / 09:08 CET/CEST Dissemination of an announcement according to the German Securities Acquisition and Takeover Act (WpÜG), trans...

Research & Analysis

Mon, 09.12.2024

Today, CompuGroup Medical SE & Co. KGaA (CGM or the Company), together with its general partner, CompuGroup Medical Management SE, its majority shareholder GT 1 Vermögensverwaltung GmbH (the Majority Shareholder), Kronen 2944 GmbH (to be renamed GT2 Beteiligungen und Software GmbH, GT2) as well as SCUR-Alpha 269 GmbH (to be renamed Caesar BidCo...

Research & Analysis

Mon, 09.12.2024

Research & Analysis

Sun, 08.12.2024

CompuGroup Medical SE & Co. KGaA (Company) confirms that the Company and the shareholder group around the founding family Gotthardt are in advanced discussions with the private equity firm CVC Capital Partners plc (CVC) regarding a potential conclusion of an investment agreement for the submission of a voluntary public tender offer to the share...

Research & Analysis

Thu, 07.11.2024

CGM drives innovation in the third quarter while recording earnings decline with almost stable revenues Koblenz - CompuGroup Medical, one of the world's leading e-health providers, recorded revenues of EUR 283.4 million in the third quarter of the 2024 financial year, slightly (-1 percent) below the previous year's level (PY: EUR 285.7 million), w...

Research & Analysis

Wed, 31.07.2024

CompuGroup Medical appoints Prof. Dr. Daniel Gotthardt as new CEO Koblenz. CompuGroup Medical announced today that the Administrative Board appoints the company founder’s son, Prof. (apl.) Dr. med. Daniel Gotthardt, as CEO of CGM effective as of September 1, 2024. The current CEO Michael Rauch will leave the company in the best mutual agreement to...

Research & Analysis

Wed, 31.07.2024

CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO Koblenz, Germany. The general partner of CompuGroup Medical SE & Co. KGaA (the “Company”) (ISIN: DE000A288904 | WKN: A28890) announces that the Administrative Board of CompuGroup Medical Management SE and CEO Michael Rauch decided today in mutual agreement to ...

Research & Analysis

Wed, 31.07.2024

CompuGroup Medical wins digitization expert Ulf Hönick for the pharmacy business Koblenz - CompuGroup Medical SE & Co. KGaA (CGM), one of the world's leading e-health providers, has gained another experienced healthcare expert. On August 1, Ulf Hönick will take over the management of CGM Lauer. Over the past few years, Ulf Hönick has supporte...

Research & Analysis

We are different

OPEN FINANCIAL

DATA & KNOWLEDGE HUB

We make the difference

Information on product placements

Legend

SMART * AD

P R O D U C T S U G G E S T I O N S

Report a bug

First Name *

Last Name

Email *

Subject *

i.e Feature x is not working

Issue happened on *

This page

Other page

Page URL

Paste the page URL here

Bug Detail *

Please give us more detailed explanation of the issue

Steps to reproduce *

Specify the steps you've done before the issue happen

Actual Result *

What's the result of the issue?

Expected Result *

What do you expect to see?

Attachment

(Optional) You can send us a screenshot, word document, or a PDF explaining the issue

Important note

You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .

Understood and confirmed *

I would like to continue *

Continue

Submit improvement suggestion/new feature

Please log in to your user account. This will allow us to contact you in case of any queries.

I would like to remain anonymous.

Subject *

e.g. New calculation method for Risk-of-Ruin-Calculator

View/Tool *

This view/tool

Another page/tool

Link to view/tool

View/Tool (specify URL/link)

Description of the proposed change/feedback *

The more comprehensible the description, the faster a feasibility check can be carried out.

General feedback on the view/tool/component/content *

Use this feedback text field for general or supplementary information

Would you use the tool and recommend it if necessary? *

Your opinion is valuable. Feel free to share it with us.

You are interested

Do you have a request? Get in contact with us

You are already a member?

Who is online? Community stats (Snapshot): 1.264 Visitors - 2.152 Registered members - 4 New registrations (Welcome!)

ayondo® 2024 - Est.: 2008 - Social network, community and online platform for investors with an affinity for the stock market - Business model that has won numerous international awards - Proprietary technology - Fintech pioneer and innovation driver in disruptive technologies

Made in Germany

ayondo-prime a²

Useful Links

About Us

Vision/Mission

Imprint

Legal

Data Protection

Cookie Guidelines

Privacy

Contact

MetaTrader 4

MetaTrader 5

ActivTrader

Education

Tools

Product Universe

FAQ

Visual Sitemap

Helpdesk

Fast lane

https://ayon.do/v

https://ayon.do/r

ayondo® - my community, my spirit

Social Media Links

ayondo® is a trademark of RSQ Technology Ventures GmbH ("RSQ"). RSQ is the operator of the Internet presence ayondo.com and its sub-sites. ayondo® as a brand represents a community of interest that is connected via a social network and common interests.

Financial literacy represents a key qualification. A key objective is to promote financial knowledge and financial literacy. The content published on the online portal is aimed at people who are interested in information and education in the field of investment, investing and trading and related topics. As a precautionary measure, we would like to point out that none of the content available on ayondo.com can be interpreted as a recommendation or invitation to buy or sell financial instruments, nor does it constitute any other advisory service. An explicit recommendation to use a particular service, information or financial instruments is not made.

Inasmuch as investment brokerage within the meaning of Section 2 (2) No. 3 of the German Securities Trading Act (WpIG) is provided via the online portal ayondo.com, RSQ acts as a contractually bound broker pursuant to Section 3 (2) WpIG. This service is provided exclusively for the account and under the liability of DonauCapital Wertpapier GmbH, Passauer Str. 5, 94161 Ruderting. In this case, the contractual partner of the customer is exclusively DonauCapital Wertpapier GmbH.

RSQ is entered as a contractually bound intermediary of DonauCapital Wertpapier GmbH in the public register maintained by the Federal Financial Supervisory Authority (BaFin) on the Internet. The register can be viewed at www.bafin.de.

If interested parties wish to take advantage of securities services with reference to CFD or FX trading, there is the option to consider offers from our cooperation partners for this purpose. Provided that this option is used, RSQ will broker trading accounts to the ActivTrades group of companies.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74% and 89% of all retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Consumer information

Imprint

smart.AD